.
logo csic-iccc

microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.

2016, Clin Investig Arterioscler. 2016 Jul-Aug;28(4):167-77.
de Gonzalo-Calvo D, Cenarro A, Civeira F, Llorente-Cortes V.
Autors del centre relacionats: Llorente-Cortés Vicenta.
Abstract
INTRODUCTION:
microRNA (miRNA) expression profile of extracellular vesicles is a potential tool for clinical practice. Despite the key role of vascular smooth muscle cells (VSMC) in cardiovascular pathology, there is limited information about the presence of miRNAs in microparticles secreted by this cell type, including human coronary artery smooth muscle cells (HCASMC). Here, we tested whether HCASMC-derived microparticles contain miRNAs and the value of these miRNAs as biomarkers.
METHODS:
HCASMC and explants from atherosclerotic or non-atherosclerotic areas were obtained from coronary arteries of patients undergoing heart transplant. Plasma samples were collected from: normocholesterolemic controls (N=12) and familial hypercholesterolemia (FH) patients (N=12). Both groups were strictly matched for age, sex and cardiovascular risk factors. Microparticle (0.1-1μm) isolation and characterization was performed using standard techniques. VSMC-enriched miRNAs expression (miR-21-5p, -143-3p, -145-5p, -221-3p and -222-3p) was analyzed using RT-qPCR.
RESULTS:
Total RNA isolated from HCASMC-derived microparticles contained small RNAs, including VSMC-enriched miRNAs. Exposition of HCASMC to pathophysiological conditions, such as hypercholesterolemia, induced a decrease in the expression level of miR-143-3p and miR-222-3p in microparticles, not in cells. Expression levels of miR-222-3p were lower in circulating microparticles from FH patients compared to normocholesterolemic controls. Microparticles derived from atherosclerotic plaque areas showed a decreased level of miR-143-3p and miR-222-3p compared to non-atherosclerotic areas.
CONCLUSIONS:
We demonstrated for the first time that microparticles secreted by HCASMC contain microRNAs. Hypercholesterolemia alters the microRNA profile of HCASMC-derived microparticles. The miRNA signature of HCASMC-derived microparticles is a source of cardiovascular biomarkers.
Copyright © 2016 Sociedad Española de Arteriosclerosis. Publicado por Elsevier España, S.L.U. All rights reserved.

KEYWORDS:
Biomarcador; Biomarker; Cell-derived microparticles; Células de músculo liso vascular; MicroARN; MicroRNAs; Micropartículas liberadas por células; Vascular smooth muscle cell
PMID: 27363781 DOI: 10.1016/j.arteri.2016.05.005

Cercador de publicacions

Cercar
pie http://www10.gencat.net/dursi/ http://www.santpau.es/ http://www.uab.es/

Institut Català de Ciències Cardiovasculars
Hospital de la Santa Creu i Sant Pau, Pavelló del Convent
Sant Antoni Maria Claret, 167 08025 Barcelona Espanya
T: +34 - 93 556 5900 F: +34 - 93 556 5559

Avis legal | Politica de Privacitat